Centene completes acquisition of national specialty pharmacy

Clayton-based Centene Corp. has completed a deal for national specialty pharmacy PANTHERx, which specializes in treating rare diseases and is based in Pittsburgh. Terms of the deal were not disclosed, but Centene President and CEO Michael Neidorff said the deal will bolster his company’s portfolio, according to a release. "We are pleased to welcome the PANTHERx team to the Centene family," Neidorff said. "PANTHERx is a leader in rare disease pharmacy and brings a unique capability to our comprehensive…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news